Arrowgrass Capital Partners Llp Lifted Facebook (FB) Stake; Alimera Sciences (ALIM) Shorts Raised By 17.61%

October 13, 2017 - By marketbeat

Alimera Sciences Incorporated (NASDAQ:ALIM) had an increase of 17.61% in short interest. ALIM’s SI was 734,800 shares in October as released by FINRA. Its up 17.61% from 624,800 shares previously. With 115,600 avg volume, 6 days are for Alimera Sciences Incorporated (NASDAQ:ALIM)’s short sellers to cover ALIM’s short positions. The SI to Alimera Sciences Incorporated’s float is 2.69%. About 67,468 shares traded. Alimera Sciences Inc (NASDAQ:ALIM) has risen 0.67% since October 13, 2016 and is uptrending. It has underperformed by 16.03% the S&P500.

Arrowgrass Capital Partners Llp increased Facebook Inc (FB) stake by 11300% reported in 2017Q2 SEC filing. Arrowgrass Capital Partners Llp acquired 141,250 shares as Facebook Inc (FB)’s stock rose 10.88%. The Arrowgrass Capital Partners Llp holds 142,500 shares with $21.52 million value, up from 1,250 last quarter. Facebook Inc now has $504.95B valuation. The stock rose 0.76% or $1.32 reaching $173.87 per share. About 11.07M shares traded. Facebook Inc (NASDAQ:FB) has risen 26.75% since October 13, 2016 and is uptrending. It has outperformed by 10.05% the S&P500.

Alimera Sciences, Inc. is a pharmaceutical company. The company has market cap of $97.37 million. The Firm is engaged in the research, development and commercialization of prescription ophthalmic pharmaceuticals. It currently has negative earnings. The Firm operates through two divisions: U.S. and International.

Investors sentiment increased to 1.07 in 2017 Q2. Its up 0.07, from 1 in 2017Q1. It improved, as 4 investors sold Alimera Sciences Inc shares while 10 reduced holdings. 8 funds opened positions while 7 raised stakes. 25.49 million shares or 0.63% less from 25.65 million shares in 2017Q1 were reported. Armistice Limited Liability Co invested in 1.05% or 5.90M shares. Palo Alto Ltd accumulated 0.2% or 3.01M shares. 27,227 were accumulated by Bankshares Of Mellon. New York-based Orbimed Lc has invested 0% in Alimera Sciences Inc (NASDAQ:ALIM). Deerfield Mngmt Communications holds 0.35% in Alimera Sciences Inc (NASDAQ:ALIM) or 4.77 million shares. 84,000 are owned by Weiss Multi. New York-based Jpmorgan Chase has invested 0% in Alimera Sciences Inc (NASDAQ:ALIM). Manufacturers Life Insur Com The reported 2,389 shares stake. Barclays Public Ltd stated it has 0% in Alimera Sciences Inc (NASDAQ:ALIM). Goldman Sachs Grp Inc Inc owns 303,823 shares for 0% of their portfolio. Parkwood Limited Liability Com holds 0.05% of its portfolio in Alimera Sciences Inc (NASDAQ:ALIM) for 228,123 shares. Strs Ohio reported 0% stake. Jw Asset Management Ltd Com holds 0.86% of its portfolio in Alimera Sciences Inc (NASDAQ:ALIM) for 966,000 shares. Fincl Bank Of Montreal Can accumulated 500 shares or 0% of the stock. Moreover, Vanguard Gru has 0% invested in Alimera Sciences Inc (NASDAQ:ALIM).

Among 3 analysts covering Alimera Sciences (NASDAQ:ALIM), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Alimera Sciences had 11 analyst reports since August 12, 2015 according to SRatingsIntel. The firm has “Buy” rating by Cowen & Co given on Tuesday, July 25. H.C. Wainwright maintained it with “Buy” rating and $500 target in Tuesday, July 11 report. The rating was maintained by Cowen & Co with “Buy” on Tuesday, July 11. The company was maintained on Tuesday, January 19 by Cantor Fitzgerald. The rating was maintained by H.C. Wainwright on Wednesday, July 26 with “Buy”. On Friday, September 16 the stock rating was upgraded by Cowen & Co to “Outperform”. H.C. Wainwright maintained Alimera Sciences Inc (NASDAQ:ALIM) on Wednesday, August 30 with “Buy” rating. The firm has “Market Perform” rating by Cowen & Co given on Friday, May 6. The stock has “Buy” rating by H.C. Wainwright on Friday, August 4. The company was maintained on Wednesday, August 12 by Cantor Fitzgerald.

Among 52 analysts covering Facebook (NASDAQ:FB), 48 have Buy rating, 2 Sell and 2 Hold. Therefore 92% are positive. Facebook had 182 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Outperform” rating by Robert W. Baird given on Thursday, July 30. The stock has “Buy” rating by Bank of America on Monday, July 24. The rating was maintained by William Blair on Thursday, July 20 with “Buy”. The firm has “Outperform” rating by Wells Fargo given on Thursday, November 3. The firm has “Market Perform” rating given on Thursday, November 3 by BMO Capital Markets. FBR Capital maintained the stock with “Outperform” rating in Thursday, July 30 report. As per Monday, July 31, the company rating was downgraded by Pivotal Research. Raymond James upgraded the shares of FB in report on Friday, January 13 to “Strong Buy” rating. As per Thursday, April 28, the company rating was maintained by Stifel Nicolaus. The rating was maintained by UBS with “Buy” on Thursday, July 27.

Since April 28, 2017, it had 0 buys, and 25 sales for $796.22 million activity. $88.97 million worth of Facebook Inc (NASDAQ:FB) shares were sold by Koum Jan. Sandberg Sheryl also sold $24.45 million worth of Facebook Inc (NASDAQ:FB) on Wednesday, May 24. On Friday, June 9 Zuckerberg Mark sold $2.50M worth of Facebook Inc (NASDAQ:FB) or 16,325 shares. $2.30 million worth of stock was sold by Wehner David M. on Friday, May 19. Another trade for 209 shares valued at $30,236 was made by Desmond-Hellmann Susan on Thursday, May 18. Cox Christopher K had sold 16,000 shares worth $2.37M. $111,404 worth of Facebook Inc (NASDAQ:FB) was sold by Stretch Colin.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By :